Physician
Right Path Treatment Center LLC
Right Path Treatment Center LLC was paid $8.99M by Medicaid between Mar 2018 and Sep 2022, across 22 billing codes. Its largest line is G9012, Other specified case management service not elsewhere classified — 32% of everything it billed.
33Billing provider infoRIGHT PATH TREATMENT CENTER LLC
VIRGINIA BEACH, VA 23452
VIRGINIA BEACH, VA 23452
33aNPI1356778138assigned 10/11/2013
33bProvider typeAddiction Medicine (Internal Medicine) Physician
28Total paid$8.99M
24GClaims187,017
24DCodes billed22
24AFirst – last monthMar 2018 – Sep 2022
Compared with peers
Next to other Addiction Medicine (Internal Medicine) Physician providers in Virginia
Rank by total paid#1 of 7
Median peer was paid$22K
This provider vs. median403×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,801 | $249K | |
| 2019 | 32,586 | $982K | |
| 2020 | 53,768 | $2.53M | |
| 2021 | 78,090 | $4.19M | |
| 2022 | 17,772 | $1.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G9012 | Other specified case management service not elsewhere classified | 32% | 12,180 | 12,049 | $2.86M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 19,088 | 13,820 | $1.34M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 13% | 15,387 | 10,036 | $1.14M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 12% | 17,918 | 12,737 | $1.07M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 8.5% | 10,647 | 7,720 | $765K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 7.4% | 24,316 | 13,124 | $662K |
| 80305 | 3.9% | 35,265 | 24,070 | $349K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.4% | 4,195 | 3,447 | $216K |
| 96127 | 1.6% | 37,245 | 25,346 | $141K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.6% | 1,417 | 1,391 | $140K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 1.1% | 1,214 | 983 | $96K |
| 99205 | Prolong outpt/office vis | <1% | 803 | 732 | $80K |
10 more codes
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,112 | $54K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 868 | $31K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 456 | $14K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 421 | $12K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 2,216 | $10K |
| 99407 | <1% | 1,092 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 57 | $5K |
| 99406 | <1% | 1,096 | $3K | |
| H0014 | Alcohol and/or drug services; ambulatory detoxification | <1% | 12 | $945.00 |
| Q3014 | Telehealth originating site facility fee | <1% | 12 | $236.84 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZHITAR, SERGEY (PRESIDENT)